Imaging Drug Resistance with Radiolabeled Molecules
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2965-2979
Author(s):
G. Vaidyanathan and M. R. Zalutsky
Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
483-499
Author(s):
Thresia Thomas, Michael A. Gallo and T. J. Thomas
Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2817-2826
Author(s):
M. Schulz and M. Eggert
Lipid, Sugar and Liposaccharide Based Delivery Systems 2
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2375-2382
Author(s):
J. Blanchfield and I. Toth
Expression Profiling of Estrogen Responsive Genes Using Genomic and Proteomic Techniques for the Evaluation of Endocrine Disruptors
Journal:
Current Pharmacogenomics
Volume:
2
Page:
255-266
Author(s):
Masao Tanji and Ryoiti Kiyama
The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1431-1452
Author(s):
David W. Moskowitz and Frank E. Johnson
p53: Fighting Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
385-402
Author(s):
Galina Selivanova
Phytoestrogen Genistein and Its Pharmacological Interactions with Synthetic Endocrine-Active Compounds
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2749-2757
Author(s):
Li You
Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms
Journal:
Current Drug Targets
Volume:
5
Page:
431-443
Author(s):
M. Veronica Gavrielides, Anita F. Frijhoff, Claudio J. Conti and Marcelo G. Kazanietz